ESR1 and gastric cancer: In order to further validate whether NCAPD3 directly targets CCND1, ESR1, and MYC to regulate gastric cancer cell proliferation, Co-IP experiments were conducted to examine if NCAPD3 directly interacts with CCND1, ESR1, and MYC.